7.48
0.54%
+0.04
SIGA Technologies Inc stock is currently priced at $7.48, with a 24-hour trading volume of 685.59K.
It has seen a +0.54% increased in the last 24 hours and a -14.81% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $7.45 pivot point. If it approaches the $7.56 resistance level, significant changes may occur.
Previous Close:
$7.44
Open:
$7.2928
24h Volume:
685.59K
Market Cap:
$532.00M
Revenue:
$139.92M
Net Income/Loss:
$68.07M
P/E Ratio:
19.68
EPS:
0.38
Net Cash Flow:
$94.78M
1W Performance:
+0.27%
1M Performance:
-14.81%
6M Performance:
+37.75%
1Y Performance:
+33.33%
SIGA Technologies Inc Stock (SIGA) Company Profile
Name
SIGA Technologies Inc
Sector
Phone
212-672-9100
Address
27 East 62nd Street, New York, NY
SIGA Technologies Inc Stock (SIGA) Latest News
SIGA Technologies (NASDAQ:SIGA) Shares Gap Down to $7.44 - Defense World
Defense World
SIGA Technologies, Inc. (NASDAQ:SIGA) Shares Acquired by First Wilshire Securities Management Inc. - MarketBeat
MarketBeat
SIGA Technologies (NASDAQ:SIGA) Shares Gap Down to $7.44 - MarketBeat
MarketBeat
3 Biotech Stocks Under $20 Worth Watching in June - Entrepreneur
Entrepreneur
SGIOY: 3 Biotech Stocks Under $20 Worth Watching in June - StockNews.com
StockNews.com
SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA) - Defense World
Defense World
SIGA Technologies Inc Stock (SIGA) Financials Data
SIGA Technologies Inc (SIGA) Revenue 2024
SIGA reported a revenue (TTM) of $139.92 million for the quarter ending December 31, 2023, a +26.31% rise year-over-year.
SIGA Technologies Inc (SIGA) Net Income 2024
SIGA net income (TTM) was $68.07 million for the quarter ending December 31, 2023, a +100.76% increase year-over-year.
SIGA Technologies Inc (SIGA) Cash Flow 2024
SIGA recorded a free cash flow (TTM) of $94.78 million for the quarter ending December 31, 2023, a +127.77% increase year-over-year.
SIGA Technologies Inc (SIGA) Earnings per Share 2024
SIGA earnings per share (TTM) was $0.95 for the quarter ending December 31, 2023, a +111.11% growth year-over-year.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
Cap:
|
Volume (24h):